zolpidem has been researched along with Ataxia in 8 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zolpidem and triazolam produced dose-dependent reductions in locomotion and environment-directed behavior and increased ataxia and procumbent posture." | 3.71 | Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. ( Cook, J; Ma, C; Platt, DM; Rowlett, JK; Spealman, RD, 2002) |
| "Diazepam (2 mg/kg) induced significant ataxia and muscle relaxation, which were completely prevented by pretreatment with flumazenil (10 mg/kg) and βCCt (20 mg/kg)." | 1.38 | The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats. ( Cook, JM; Divljaković, J; Milić, M; Rallapalli, S; Savić, MM; Timić, T; van Linn, ML, 2012) |
| "Zolpidem (Stilnox) is a non-benzodiazepine hypnotic drug of the imidazopyridine class intended for treatment of insomnia in humans." | 1.36 | Zolpidem poisoning in a cat. ( Czopowicz, M; Frymus, T; Szalus-Jordanow, O, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forrester, MB | 1 |
| Czopowicz, M | 1 |
| Szalus-Jordanow, O | 1 |
| Frymus, T | 1 |
| Milić, M | 1 |
| Divljaković, J | 1 |
| Rallapalli, S | 1 |
| van Linn, ML | 1 |
| Timić, T | 1 |
| Cook, JM | 1 |
| Savić, MM | 1 |
| Platt, DM | 1 |
| Rowlett, JK | 1 |
| Spealman, RD | 1 |
| Cook, J | 1 |
| Ma, C | 1 |
| Trapani, G | 3 |
| Lopedota, A | 1 |
| Boghetich, G | 1 |
| Latrofa, A | 3 |
| Franco, M | 3 |
| Sanna, E | 3 |
| Liso, G | 3 |
| Kohut, SJ | 1 |
| Ator, NA | 1 |
| Pantaleo, MR | 2 |
| Provenzano, MR | 1 |
| Maciocco, E | 1 |
| Massa, F | 1 |
| Tuveri, F | 1 |
8 other studies available for zolpidem and Ataxia
| Article | Year |
|---|---|
Pattern of pediatric zolpidem ingestions reported to Texas poison control centers, 2000 to 2006.
Topics: Accidents, Home; Ataxia; Child, Preschool; Dose-Response Relationship, Drug; Female; First Aid; Guid | 2009 |
Zolpidem poisoning in a cat.
Topics: Animals; Antidotes; Ataxia; Cat Diseases; Cats; Flumazenil; Hyperkinesis; Hypnotics and Sedatives; M | 2010 |
The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.
Topics: Animals; Ataxia; Benzodiazepines; Benzodiazepinones; Carbolines; Diazepam; Flumazenil; GABA-A Recept | 2012 |
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Topics: Animals; Ataxia; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Drug Interactions; F | 2002 |
Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Ataxia; beta-Cyclodextrins; Chemistry, Pharmaceutical; C | 2003 |
Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
Topics: Animals; Ataxia; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychologi | 2008 |
Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000.
Topics: Animals; Ataxia; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Hypnot | 1999 |
Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Ataxia; beta-Cyclodextrins; Cyclodextrins; gamma-Cyclode | 2000 |